Llama-inspired nanobodies 'remarkably active' To view this email as a web page,
click here With Delta variant surging, FDA hustles to grant Pfizer's COVID-19 vaccine a full approval: reports KFF survey: Majority of unvaccinated adults think shot is riskier than contracting COVID-19 Pitt's inhalable anti-COVID nanobodies, inspired by llamas, 'remarkably active' against Delta variant: study With supply problems solved, Novavax inks deal to supply Europe with up to 200M COVID-19 vaccines COVID-19 tracker: WHO calls for a booster moratorium; Tuberculosis vaccine could help severe patients Survey: Roughly 1 in 7 people got low acuity care via telehealth instead of going to ER How a century-old tuberculosis vaccine may help fight severe COVID-19 Featured Story By Kevin Dunleavy The FDA has accelerated its process to grant full approval to the Pfizer-BioNTech COVID-19 vaccine, installing an unofficial deadline of Labor Day, according to the New York Times. read more |
| |
---|
| Top Stories By Robert King A new survey from Kaiser Family Foundation found a slight majority of unvaccinated adults believe getting the COVID-19 vaccine is riskier than the virus itself. read more By Arlene Weintraub A University of Pittsburgh team studied tiny anti-COVID antibodies derived from llamas to determine how effective they might be at fighting emerging variants, including Delta. They discovered that the drugs, called nanobodies, can disarm the virus and its variants using any of three different pathways. read more By Kevin Dunleavy After delaying a COVID-19 vaccine supply agreement to Europe because of production problems, Novavax has finalized the deal, which will provide the EU with 200 million doses. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The World Health Organization has called for a booster shot moratorium through at least September in an effort to provide COVID-19 vaccines to poor, supply-strapped nations. Researchers in India have found that a century-old tuberculosis vaccine could help those with severe COVID-19. Plus more. read more By Robert King A new survey found that about one in seven patients got low acuity care via telehealth rather than going to the emergency department as Congress mulls permanent flexibilities. read more By Angus Liu A research group in India has found that the century-old tuberculosis vaccine BCG may have potential for controlling severe COVID-19 in elderly patients by reducing blood levels of proinflammatory cytokines. It's not the first time scientists have proposed repurposing BCG in other diseases. read more | |